RxDoctor Payments DataLook up a doctor →

Kent Grotefendt, MD

Family Medicine · Ooltewah, TNNPI 1467439026

Payments from drug & device makers

$17,383in general payments, 2019–2025

Across 1,169 payments — averaging $14.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$3K
  • Pfizer$2K
  • AbbVie$1K
  • Lilly USA, LLC$963
  • Johnson & Johnson$925
  • Amgen$864
  • plus $8K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk271$3,461
Pfizer124$1,576
AbbVie(2 entities)83$1,231
Lilly USA, LLC80$963
Johnson & Johnson61$925
Amgen(2 entities)72$864
AstraZeneca41$837
Bayer49$832
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC39$667
Novartis33$587
Boehringer Ingelheim44$553
GSK24$390
Abbott18$365
Astellas Pharma US Inc14$324
Merck24$287
Takeda Pharmaceuticals U.S.A., Inc.18$282
Amarin Pharma, Inc.16$267
Esperion Therapeutics, Inc.8$232
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)15$211
Sanofi-aventis U.S. LLC12$177
Biohaven Pharmaceuticals, Inc.10$177
Biohaven Pharmaceutical Holding Company Ltd.11$172
Otsuka America Pharmaceutical, Inc.3$165
Phathom Pharmaceuticals, Inc.7$147
Corcept Therapeutics6$121
Xeris Pharmaceuticals, Inc.5$103
Boston Scientific2$97
Eisai Inc.6$89
Evoke Pharma, Inc.5$89
E.r. Squibb & Sons, L.L.C.6$89
Jazz Pharmaceuticals Inc.4$81
Antares Pharma, Inc.5$78
Genentech USA, Inc.6$78
Optinose US, Inc.3$68
Inspire Medical Systems, Inc.3$65
Insulet Corporation2$62
Medtronic2$45
Idorsia Pharmaceuticals US Inc3$44
Sumitomo Pharma America, Inc.2$41
Nevro Corp.2$38
Supernus Pharmaceuticals, Inc.2$36
Dexcom, Inc.2$34
Exact Sciences2$29
Paratek Pharmaceuticals, Inc.2$28
Teva Pharmaceuticals USA, Inc.2$28
Lundbeck LLC1$28
Biogen1$26
Mylan Specialty L.p.2$25
Kowa Pharmaceuticals America, Inc.2$25
Verona Pharma, Inc.1$24
Corium, LLC1$23
Neurocrine Biosciences, Inc.1$21
Irhythm Technologies, Inc.1$20
Upsher-smith Laboratories LLC1$19
Alkermes, Inc.1$19
Shield Therapeutics Inc1$17
Aytu Biopharma, Inc.1$16
Halozyme Inc1$15
Viatris Specialty LLC1$15
IBSA Pharma Inc.1$15

How this compares

$17,383 in reported general payments places this provider in the 95th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee →

Medicare billing

Part B allowed, 2024
$188,631
Medicare patients
392
Services billed
12,414

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Ooltewah

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →